Systemic Treatments for Alopecia Areata Registry
Recruiting
Observational Study
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
Hair Loss
Hair Diseases
Alopecia
Alopecia Drugs
Autoimmune Diseases
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with alopecia areata;
* Starting/using a systemic treatment for alopecia areata;
* Informed consent for registry participation obtained from patient and/or caretaker.
Exclusion Criteria:
* Not sufficiently capable of understanding the Dutch language;
* Not willing …
Contacts